Giorgi M, Miele A, Cardarelli S, Giorgi A, Massimi M, Biagioni S
Int J Mol Sci. 2023; 24(2).
PMID: 36674621
PMC: 9862819.
DOI: 10.3390/ijms24021108.
Cardarelli S, Miele A, Campolo F, Massimi M, Mancini P, Biagioni S
Int J Mol Sci. 2022; 23(15).
PMID: 35955722
PMC: 9368758.
DOI: 10.3390/ijms23158587.
Schiavi S, Carbone E, Melancia F, Di Masi A, Jarjat M, Brau F
Transl Psychiatry. 2022; 12(1):119.
PMID: 35338117
PMC: 8956682.
DOI: 10.1038/s41398-022-01885-2.
Ragusa F, Panera N, Cardarelli S, Scarsella M, Bianchi M, Biagioni S
Cancers (Basel). 2021; 13(9).
PMID: 34062786
PMC: 8125776.
DOI: 10.3390/cancers13092182.
Carvalho T, Cardarelli S, Giorgi M, Lenzi A, Isidori A, Naro F
Int J Mol Sci. 2021; 22(5).
PMID: 33807511
PMC: 7961729.
DOI: 10.3390/ijms22052593.
Measuring cAMP Specific Phosphodiesterase Activity: A Two-step Radioassay.
Blair C, Ling J, Baillie G
Bio Protoc. 2021; 10(7):e3581.
PMID: 33659551
PMC: 7842805.
DOI: 10.21769/BioProtoc.3581.
Milestones in the development and implementation of FRET-based sensors of intracellular signals: A biological perspective of the history of FRET.
Deal J, Pleshinger D, Johnson S, Leavesley S, Rich T
Cell Signal. 2020; 75:109769.
PMID: 32898611
PMC: 7679057.
DOI: 10.1016/j.cellsig.2020.109769.
Effects of Synergistic Inhibition on α-glucosidase by Phytoalexins in Soybeans.
Son H, Yoon E, Yoo C, Park C, Bae M, Kim T
Biomolecules. 2019; 9(12).
PMID: 31817312
PMC: 6995600.
DOI: 10.3390/biom9120828.
A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease.
McArthur J, Svenstrup N, Chen C, Fricot A, Carvalho C, Nguyen J
Haematologica. 2019; 105(3):623-631.
PMID: 31147439
PMC: 7049346.
DOI: 10.3324/haematol.2018.213462.
Cyclic nucleotide signalling compartmentation by PDEs in cultured vascular smooth muscle cells.
Zhang L, Bouadjel K, Manoury B, Vandecasteele G, Fischmeister R, Leblais V
Br J Pharmacol. 2019; 176(11):1780-1792.
PMID: 30825186
PMC: 6514293.
DOI: 10.1111/bph.14651.
The phosphodiesterase 5 inhibitor, KJH-1002, reverses a mouse model of amnesia by activating a cGMP/cAMP response element binding protein pathway and decreasing oxidative damage.
Zhang L, Seo J, Li H, Nam G, Yang H
Br J Pharmacol. 2018; 175(16):3347-3360.
PMID: 29847860
PMC: 6057906.
DOI: 10.1111/bph.14377.
Targeting the dopamine D receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performance.
Pekcec A, Schulert N, Stierstorfer B, Deiana S, Dorner-Ciossek C, Rosenbrock H
Br J Pharmacol. 2018; 175(14):3021-3033.
PMID: 29726015
PMC: 6016630.
DOI: 10.1111/bph.14350.
Cardiomyocyte Membrane Structure and cAMP Compartmentation Produce Anatomical Variation in βAR-cAMP Responsiveness in Murine Hearts.
Wright P, Bhogal N, Diakonov I, Pannell L, Perera R, Bork N
Cell Rep. 2018; 23(2):459-469.
PMID: 29642004
PMC: 5912947.
DOI: 10.1016/j.celrep.2018.03.053.
Atropine augments cardiac contractility by inhibiting cAMP-specific phosphodiesterase type 4.
Perera R, Fischer T, Wagner M, Dewenter M, Vettel C, Bork N
Sci Rep. 2017; 7(1):15222.
PMID: 29123207
PMC: 5680190.
DOI: 10.1038/s41598-017-15632-x.
Use of the KlADH3 promoter for the quantitative production of the murine PDE5A isoforms in the yeast Kluyveromyces lactis.
Cardarelli S, Giorgi M, Naro F, Malatesta F, Biagioni S, Saliola M
Microb Cell Fact. 2017; 16(1):159.
PMID: 28938916
PMC: 5610471.
DOI: 10.1186/s12934-017-0779-5.
The single cyclic nucleotide-specific phosphodiesterase of the intestinal parasite Giardia lamblia represents a potential drug target.
Kunz S, Balmer V, Sterk G, Pollastri M, Leurs R, Muller N
PLoS Negl Trop Dis. 2017; 11(9):e0005891.
PMID: 28915270
PMC: 5617230.
DOI: 10.1371/journal.pntd.0005891.
Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of Dystonia.
DAngelo V, Castelli V, Giorgi M, Cardarelli S, Saverioni I, Palumbo F
J Neurosci. 2017; 37(8):2112-2124.
PMID: 28115486
PMC: 6705690.
DOI: 10.1523/JNEUROSCI.3207-15.2016.
Effects of a novel phosphodiesterase 10A inhibitor in non-human primates: A therapeutic approach for schizophrenia with improved side effect profile.
Masilamoni G, Uthayathas S, Koenig G, Leventhal L, Papa S
Neuropharmacology. 2016; 110(Pt A):449-457.
PMID: 27539962
PMC: 5028314.
DOI: 10.1016/j.neuropharm.2016.08.012.
Sustained exposure to catecholamines affects cAMP/PKA compartmentalised signalling in adult rat ventricular myocytes.
Fields L, Koschinski A, Zaccolo M
Cell Signal. 2015; 28(7):725-32.
PMID: 26475678
PMC: 4872538.
DOI: 10.1016/j.cellsig.2015.10.003.
Estimating the magnitude of near-membrane PDE4 activity in living cells.
Xin W, Feinstein W, Britain A, Ochoa C, Zhu B, Richter W
Am J Physiol Cell Physiol. 2015; 309(6):C415-24.
PMID: 26201952
PMC: 4572370.
DOI: 10.1152/ajpcell.00090.2015.
